BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1823558)

  • 1. Anti-asialo GM1 antibody suppression of cyclophosphamide-induced diabetes in NOD mice.
    Maruyama T; Watanabe K; Takei I; Kasuga A; Shimada A; Yanagawa T; Kasatani T; Suzuki Y; Kataoka K; Saruta
    Diabetes Res; 1991 May; 17(1):37-41. PubMed ID: 1823558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The suppressive effect of anti-asialo GM1 antibody on low-dose streptozotocin-induced diabetes in CD-1 mice.
    Maruyama T; Watanabe K; Yanagawa T; Kasatani T; Kasuga A; Shimada A; Takei I; Suzuki Y; Kataoka K; Saruta T
    Diabetes Res; 1991 Apr; 16(4):171-5. PubMed ID: 1802483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice.
    Yoshino H; Ueda T; Kawahata M; Kobayashi K; Ebihara Y; Manabe A; Tanaka R; Ito M; Asano S; Nakahata T; Tsuji K
    Bone Marrow Transplant; 2000 Dec; 26(11):1211-6. PubMed ID: 11149733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of anti-asialo GM1 antibody-sensitive cells in the implementation of tumor-specific T cell-mediated immunity in vivo.
    Yoshioka T; Sato S; Fujiwara H; Hamaoka T
    Jpn J Cancer Res; 1986 Aug; 77(8):825-32. PubMed ID: 3093429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of pulmonary tumour metastasis in mice by recombinant human interleukin-2: role of asialo GM1-positive cells.
    Hinuma S; Naruo K; Ootsu K; Houkan T; Shiho O; Tsukamoto K
    Immunology; 1987 Feb; 60(2):173-9. PubMed ID: 3493209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
    Matsumoto M; Yagi H; Kunimoto K; Kawaguchi J; Makino S; Harada M
    Cell Immunol; 1993 Apr; 148(1):189-97. PubMed ID: 8098666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice.
    Gorelik E
    Cancer Res; 1987 Feb; 47(3):809-15. PubMed ID: 3802083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recombinant human IGF-1 prevents type 1 diabetes in female non-obese diabetic mice].
    Liu F; Yu M; Zhu Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Sep; 34(5):281-3. PubMed ID: 11372396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of diabetes but not insulitis in NOD mice injected with antibody to CD4.
    Hayward AR; Shriber M; Cooke A; Waldmann H
    J Autoimmun; 1993 Jun; 6(3):301-10. PubMed ID: 8104407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short administration of polyclonal anti-T cell antibody (ALS) in NOD mice with extensive insulitis prevents subsequent development of autoimmune diabetes.
    Ogawa N; Minamimura K; Kodaka T; Maki T
    J Autoimmun; 2006 Jun; 26(4):225-31. PubMed ID: 16713179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cells are required for accelerated type 1 diabetes driven by interferon-beta.
    Alba A; Planas R; Clemente X; Carrillo J; Ampudia R; Puertas MC; Pastor X; Tolosa E; Pujol-Borrell R; Verdaguer J; Vives-Pi M
    Clin Exp Immunol; 2008 Mar; 151(3):467-75. PubMed ID: 18190608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo administration of anti-asialo-GM1 antibody enhances splenic clearance of Listeria monocytogenes.
    Schultheis RJ; Kearns RJ
    Nat Immun Cell Growth Regul; 1990; 9(6):376-86. PubMed ID: 2128370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of asialo GM 1 positive cells in the control of metastatic spread of tumor cells in mice].
    Shibuya M; Saijo N; Ozaki A; Beppu Y; Shimizu E; Takizawa T; Hoshi A
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1781-6. PubMed ID: 6882003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of B-cell differentiation by natural killer (asialo GM1+) cells in mice.
    Suzuki S; Suzuki R; Onta T; Kumagai K
    Nat Immun Cell Growth Regul; 1986; 5(2):75-89. PubMed ID: 3487716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of asialo GM1 and other antigens and glycolipids on natural killer cells and spleen leukocytes in virus-infected mice.
    Yang H; Yogeeswaran G; Bukowski JF; Welsh RM
    Nat Immun Cell Growth Regul; 1985; 4(1):21-39. PubMed ID: 3875791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis.
    O'Brien BA; Harmon BV; Cameron DP; Allan DJ
    J Pathol; 2000 May; 191(1):86-92. PubMed ID: 10767724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice.
    Habu S; Fukui H; Shimamura K; Kasai M; Nagai Y; Okumura K; Tamaoki N
    J Immunol; 1981 Jul; 127(1):34-8. PubMed ID: 7240748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrimination between macrophage-and NK-type tumoricidal activities via anti-asialo GM1 antibody.
    Keller R; Bächi T; Okumura K
    Exp Cell Biol; 1983; 51(3):158-64. PubMed ID: 6852344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide.
    Qin HY; Singh B
    J Autoimmun; 1997 Jun; 10(3):271-8. PubMed ID: 9218754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Destruction of pancreatic islet cells by cytotoxic T lymphocytes in nonobese diabetic mice.
    Nagata M; Yokono K; Hayakawa M; Kawase Y; Hatamori N; Ogawa W; Yonezawa K; Shii K; Baba S
    J Immunol; 1989 Aug; 143(4):1155-62. PubMed ID: 2663991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.